🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to evaluate lot-lot consistency of Recombinant Human Papillom...
Status
Completed
Location
Dongtai City Center for Disease Control and Prevention Dongtai, Jiangsu
Start Date
2020-05-01
Trial ID
NCT05426148
The main aim of this vaccine is to prevent cervical cancer in women. Howeve...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-04-05
Trial ID
NCT00309166
Treatments Being Tested
This phase Ⅱ clinical study was designed to evaluate the immunogenicity and...
Status
Unknown
Location
Multiple Locations
Start Date
2016-03-24
Trial ID
NCT02710851
Human papillomavirus infection has clearly been recognized as the cause of ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-07-28
Trial ID
NCT00344032
Treatments Being Tested
This extension study aims to evaluate the long-term protection and immune r...
Status
Active Not Recruiting
Location
Lingchuan Center for Disease Control and Prevention
Start Date
2023-03-27
Trial ID
NCT06776055
Treatments Being Tested
This is a Phase III clinical trial of the novel recombinant HPV 16/18 bival...
Status
Completed
Location
Cancer Institute ＆ Hospital Chinese Academy of Medical Sciences
Start Date
2012-11-22
Trial ID
NCT01735006
Treatments Being Tested
Human Papilloma virus (HPV) are viruses that cause a common infection of th...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-05-06
Trial ID
NCT00122681
Treatments Being Tested
Infection with human papillomavirus (HPV) has been clearly established as t...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-04-09
Trial ID
NCT00652938
Treatments Being Tested
Human papillomavirus infection has clearly been recognized as the cause of ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-06-11
Trial ID
NCT00485732
Treatments Being Tested
This protocol posting deals with objectives \& outcome measures of the exte...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-10
Trial ID
NCT00316706
Treatments Being Tested